Physician

Rajeev Mehta, MD

According to 2025 Medicare claims, Rajeev Mehta, MD (NPI: 1114995545) practices pulmonary disease in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is INDIANA UNIVERSITY HEALTH BALL MEMORIAL PHYSICIANS, INC. (NPI: 1235455544; TIN: 351925641) and primary practice location at 47303-3428. Mehta is affiliated with the Indiana University Health ACO, Inc. (ACO ID: D0034), participating under the REACH model.

Mehta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 469 traditional Medicare patients, billed 2,479 HCPCS/CPT codes, and received $153,029 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,003 prescription claims across 469 beneficiaries totaling $1,494,633 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,112 claims. Open Payments data shows 70 records totaling $3,664. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $334,400 to $153,029. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $439,423 to $1,494,633. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$167K$334K2015 Medicare payment: $334,400 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $303,172 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $277,014 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $265,459 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $246,830 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $199,552 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $188,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $184,311 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $182,745 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $153,029 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157979,062$334,400
20168747,244$303,172
20178476,008$277,014
20187945,580$265,459
20197945,001$246,830
20206633,453$199,552
20216183,044$188,986
20225633,162$184,311
20235323,074$182,745
20244692,479$153,029

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$747K$1.5M2015 Drug cost: $439,423 (USD; Tot_Drug_Cst)2016 Drug cost: $522,608 (USD; Tot_Drug_Cst)2017 Drug cost: $766,406 (USD; Tot_Drug_Cst)2018 Drug cost: $945,491 (USD; Tot_Drug_Cst)2019 Drug cost: $1,077,979 (USD; Tot_Drug_Cst)2020 Drug cost: $1,156,034 (USD; Tot_Drug_Cst)2021 Drug cost: $1,275,484 (USD; Tot_Drug_Cst)2022 Drug cost: $1,421,562 (USD; Tot_Drug_Cst)2023 Drug cost: $1,402,422 (USD; Tot_Drug_Cst)2024 Drug cost: $1,494,633 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153011,891$439,423
20163572,179$522,608
20173992,599$766,406
20184002,922$945,491
20194233,016$1,077,979
20204132,984$1,156,034
20214413,290$1,275,484
20224683,517$1,421,562
20234603,519$1,402,422
20244694,003$1,494,633

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$83K$166K2015 Medicare payment: $101,435 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $75,958 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $78,267 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $79,605 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $114,800 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $80,130 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $85,730 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $99,683 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $88,913 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $165,527 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015160963$101,435
20162661,323$75,958
20173151,502$78,267
20183111,470$79,605
20193291,541$114,800
20202441,131$80,130
20212001,079$85,730
2022135987$99,683
2023163918$88,913
20241931,112$165,527

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more211347$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more130157$53
94729Test to examine how well the lungs exchange gases222224$36
94727Test to determine lung volumes using gas dilution or washout222224$30
94010Test to measure expiratory airflow and volume208210$17

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60027,180$561,841
Spiriva RespimatTiotropium Bromide1567,801$134,538
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr1256,210$96,038
Stiolto RespimatTiotropium Br/Olodaterol Hcl1036,126$95,594
NucalaMepolizumab21644$84,076

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7699Noc drugs, inhalation solution administered through dmeNN/R25$59,556
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramNN/R36$27,082
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY37252$24,433
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R19$16,114
E0465Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)YN/R12$10,415

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$3,664GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rajeev Mehta, MD?

Tedicare shows public-source Medicare data for Rajeev Mehta, MD (NPI 1114995545), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajeev Mehta, MD have ACO affiliation data?

Rajeev Mehta, MD is shown with ACO affiliation data for Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Rajeev Mehta, MD?

Rajeev Mehta, MD is linked to INDIANA UNIVERSITY HEALTH BALL MEMORIAL PHYSICIANS, INC. (billing NPI 1235455544) in the available physician profile data.

Does Rajeev Mehta, MD have Open Payments data?

Rajeev Mehta, MD has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.